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Abstract
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Biodegradable electrospun poly(ε-caprolactone) (PCL) scaffolds were coated with platelet-rich
plasma (PRP) to improve cell adhesion and proliferation. PRP was obtained from human buffy
coat, and tested on human adipose-derived mesenchymal stem cells (MSC) to confirm cell
proliferation and cytocompatibility. Then, PRP was adsorbed on the PCL scaffolds via
lyophilization, which resulted in uniform sponge-like coating of 2.85 (s.d. 0.14) mg/mg. The
scaffolds were evaluated regarding mechanical properties (Young’s modulus, tensile stress and
tensile strain), sustained release of total protein and growth factors (PDGF-BB, TGF-β1 and
VEGF), and hemocompatibility. MSC seeded on the PRP-PCL nanofibers showed an increased
adhesion and proliferation compared to pristine PCL fibers. Moreover, the adsorbed PRP enabled
angiogenesis features observed as neovascularization in a chicken chorioallantoic membrane
(CAM) model. Overall, these results suggest that PRP-PCL scaffolds hold promise for tissue
regeneration applications.
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1. Introduction
Electrospinning was first described in patents by Cooley in the early 1900’s [1] and the first
reports on using this technique to obtain cellulose acetate, cellulose propionate and woolcellulose acetate fibers were published in the 1930’s [2]. The technique consists of placing a
polymer solution in a syringe and connecting it to a high power supply, which generates a
high voltage difference (5 kV to 30 kV) between the syringe needle and a grounded target.
As the polymer is ejected, the electrical charges on the polymer solution promote solvent
evaporation, thus forming a dry polymer fiber that travels in a chaotic pattern and deposits
on the grounded target [3]. Variables of the process, such as polymer concentration, solvent
volatility, solution conductivity, applied voltage, solution flow rate, and gap between syringe
and collector greatly determine fiber properties [4].
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Nanofibrous scaffolds obtained through electrospinning process consist of fibers with an
average diameter between 50 and 5000 nm and tunable surface area, morphology,
mechanical performance or length/diameter ratio [5]. A large variety of natural and synthetic
materials can be electrospun to prepare suitable scaffolds for cell seeding and proliferation,
being this technique particularly convenient for regenerative medicine [6]. For example,
electrospinning can render aligned nanofibers with spatial distribution similar to organized
tissues, suitable for tendon regeneration [7], or aligned-to-random scaffolds for mimicking
the structure of the tendon-to-bone insertion site [8]. Layered composite electrospun
scaffolds have been shown useful to regenerate endothelium due to their analogous structure
with natural blood vessels [9], and nanofibrous electrospun scaffolds may be suitable as
dermal substitutes for skin regeneration [10]. Moreover, the technique enables the
combination of natural biomaterials, synthetic polymers and growth factors [11].
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Poly(ε-caprolactone) (PCL) is a biocompatible and biodegradable polymer suitable for
preparing electrospun nanofibers. Unlike other polymers extensively used in biomedical
applications, such as polylactic acid (PLA) or polyglycolic acid (PGA), hydrolysis of PCL
does not produce a local acidic environment that could compromise cell growth [12–14].
Nevertheless, mammalian cell attachment on PCL scaffolds is limited due to its
hydrophobicity and inertness. This drawback can be overcome by means of hydrophilization
techniques, such as wet chemical and plasma treatment, surface graft polymerization or
physical adsorption [15, 16], which also enable the incorporation of bioactive molecules to
the scaffold. For example, drugs, proteins and gene material have been adsorbed onto
scaffold surfaces to form coatings that promote cell adhesion and proliferation [15, 17, 18].
Platelet-rich plasma (PRP) is becoming an attractive alternative to the use of expensive and
immunological-risky recombinant growth factors, due to its autologous nature and easiness
of obtainment [19]. Platelets play a crucial role in the inflammatory response and the
regeneration process; they release high amounts of biologically active growth factors, some
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of which are involved in different healing stages. PRP growth factors include transforming
growth factor (TGF-β1), basic fibroblast growth factor (bFGF), epidermal growth factor
(EGF), vascular endothelial growth factor (VEGF), insulin-like growth factor, and platelet
derived growth factor (PDGF) [20] with chemotactic, mitogenic, morphogenic and
metabolic effects, which are involved in cell recruitment, proliferation, morphogenesis and
differentiation. Growth factors also play a remarkable role in the cell-extracellular matrix
communication during regeneration activity [21]. Electrospinning of PRP solely or
combined with biodegradable polymers, such as PCL or PGA, has been also evaluated [22].
The resultant scaffolds showed excellent penetration and proliferation of adipose-derived
stem cells. PRP has been loaded in chitosan gels and sponges for sustained release of growth
factors [23]. Just recently, PRP has been physically adsorbed onto Vicryl® (PGA fibers) and
then freeze-dried as a way to preserve the related growth factors until use, instead of the
immediate preparation of the PRP from patients’ blood [24].
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The aim of this study was to prepare bioactive PCL scaffolds by coating electrospun fibers
with PRP via impregnation followed by freeze-drying. It was hypothesized that the
adsorption of PRP on the fibers would enhance cell attachment and proliferation, without
detrimental effects on the preparation and the mechanical behavior of the fibers. Moreover,
sustained release, ideally sequential delivery, of some growth factors from the scaffold may
be beneficial for tissue regeneration. Compared to direct electrospinning of polymer and
PRP mixtures, coating of preformed fibers may be advantageous as it enables the fibers to
be prepared according to preset protocols and then to be functionalized with PRP (from
donor pools or from an specific patient) just before use. This approach can avoid concerns
regarding storage and stability of the preformed fibers and also of PRP (as coelectrospinning requires dissolution of the growth factors in organic solvents) and may also
enable tuning the quantity of PRP deposited according to a given application. Once
implanted, PRP adsorbed on the scaffold may create an environment rich in growth factors
able to promote tissue repair/regeneration.

2. Materials and methods
2.1 Materials
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Poly-ε-caprolactone (PCL; Mn = 70–90K), tetrahydrofuran 99% (THF) and N,Ndimethylformamide 99.8% (DMF) were purchased from Sigma-Aldrich (St. Louis, MO,
USA) and used without further purification. Mesenchymal stem cells (MSC) StemPRO®
human adipose-derived stem cells were from Gibco (Invitrogen, USA), and murine
fibroblasts (CCL-163) from the American Type Culture Collection (ATCC, USA). All other
reagents were analytical grade.
2.2 Platelet Rich Plasma (PRP) preparation and characterization
2.2.1 PRP preparation—Human PRP was obtained from human buffy coat (Centro de
Transfusión de Galicia, Spain) and transferred to 50 mL Falcon tubes (BD Bioscience,
USA). The buffy coat was centrifuged at 400g for 15 minutes, and the supernatant rich in
platelets was collected and analyzed using a Coulter counter (Beckman, USA; 100μm slit)
resulting in 3·106 platelets/μL. Tubes with 1 mL of PRP were activated in separate by
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freeze-thaw cycles: aliquots were stored at −80 °C for 24 hours, followed by 1 hour at room
temperature and frozen again. After 3 cycles, tubes were centrifuged at 12000g for 10
minutes at 4 °C, and the supernatant containing growth factors was recovered and kept
frozen at −80 °C until use (as liquid) or freeze-drying. Each mL of PRP led to 72.5 mg after
freeze-drying. Total protein and VEGF present in freeze-dried PRP were quantified, in
sextuplicate, by means of BCA analysis and an ELISA kit (RayBiotech, USA), respectively.
2.2.2 Effect of PRP on MSC proliferation—Human MSC (2·104 cells) were seeded in
24-well plates with either 1 mL of MSC medium (MesenPro RS, 2% growth supplement
MesenPro RS, Gibco USA, 1% Pen-Strep) (control) or 1 mL of PRP-rich medium
(MesenPro RS:PRP solution:Pen-Strep 89:10:1 vol%; equivalent to 7.25 mg freeze-dried
PRP/mL), and then incubated in a humidified atmosphere with 5% CO2 at 37 °C. Cell
proliferation was tested at 1, 3 and 7 days using the MTT assay (Roche, Switzerland) and
results were read at 550 nm (UV Bio-Rad Model 680 microplate reader, USA). All
experiments were carried out in triplicate.

NIH-PA Author Manuscript

2.2.3 Histochemical analysis of PRP effect—An Alcian blue staining was done to
evaluate extracellular matrix (ECM) synthesis during MSC proliferation. MSC were seeded
in 24-well plates following the same protocol as for the proliferation assay (negative control
and 10% PRP supplemented medium), with the medium being renewed every 3 days. After
7 days, cells were rinsed with PBS and fixed with 4% formaldehyde solution for 30 minutes.
Then, they were rinsed again with PBS and 1% Alcian blue solution in 0.1N HCl was added.
After 30 minutes, wells were rinsed with 0.1N HCl and then with water. Cells were
observed using light microscopy to search for blue staining indicative of synthesis of
glycosaminoglycans. Differentiation of MSC to other cell lineages such as osteoblasts was
evaluated recording alkaline phosphatase (ALP) activity after 7 days of growth. Cells were
fixed with 4% paraformaldehyde solution for 5 minutes, washed twice with PBS and
incubated in darkness with naphthol ASMX-phosphate and 0.1% fast violet in 56 mM
AMPD (2-amino-2-methyl propanediol) for 30 minutes. Then, the cells were observed under
light microscopy.
2.3 PCL scaffolds preparation and characterization
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2.3.1 Preparation—Aliquots (4 mL) of PCL solution (10 wt.%) in a THF:DMF (1:1) were
electrospun onto an aluminum grounded target placed at 24 cm from the needle tip. PCL
polymer nanofibers were obtained using a 10 mL glass syringe with a 22-needle gauge (0.7
mm OD × 0.4 mm ID) at a flow rate of 0.05 mL/minutes. The flow rate was controlled using
a KDS 210 pump (KD Scientific Holliston Inc., MA). The high power supply used was an
ES30P-5W purchased from Gamma High Voltage Research (Ormond Beach, FL), and the
equipment was attached to the needle tip through an alligator clip with a voltage difference
of 25 kV.
Scaffolds (cut as disks of 1.33 cm2 and ca. 5 mg weight) were washed with ethanol for 10
minutes and with PBS (3 times), and then each disc was immersed in activated PRP (1 mL),
kept under stirring for 4 hours at 4°C, transferred to 24-well plates, and freeze-dried at
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−80°C. The amount of PRP deposited on the disks was estimated gravimetrically from at
least six replicate samples. Thereinafter, PRP-coated PCL is referred as PRP-PCL scaffold.
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2.3.2 Physical characterization—Scanning electron microscopy (SEM) images of
scaffold disks of 1.33 cm2 were taken using a Zeiss Ultra Plus (Germany) at various
magnifications after coating with a gold-palladium layer. The diameters of the nanofibers as
well as the length of the pores among the fibers were measured in at least 100 different
points. The mechanical behavior of the nanofiber mats (cut in the form of a “dog-bone”
shape using a die that afforded samples with 2.75 mm wide at their narrowest point and a
gauge length of 7.5 mm) was investigated using an INSTRON® tensile tester 5943 with a 25
N maximum load cell under a crosshead speed of 10 mm/minutes. Ten specimens were
tested for tensile behavior and the average values reported. Water contact angles (10 μL)
were measured at various times using a Phoenix-300 plus video-based optical contact angle
measuring device fitted with SurfaceWare software (SEO, Korea). Attenuated total
reflectance Fourier transform infrared (ATR-FTIR) spectra were recorded on a Varian 670IR (Varian Inc, USA) in a 400–4000 cm−1 range at a resolution of 2 cm−1.
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2.3.3 Hydrolytic degradation—Fiber mats were immersed in USP phosphate buffer pH
7.4 at 37°C, and their erosion rate was determined monitoring the weight loss. After 5 days
in buffer, mats were washed with water, dried at 37°C for 3 days, and weighed. The
washing, drying, and immersion cycles were repeated 5 times until 40 days.
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2.3.4 Growth factors release from PRP-PCL scaffolds—Total protein and PDGFBB, TGF-β1 and VEGF release tests were carried out placing portions of UV-sterilized
PRP-PCL scaffolds (1.33 cm2) in 24-well plates to which 1 mL PBS was added and then
incubated at 37 °C. At 4 hours, 1, 3 and 7 days samples (0.5 mL) of the release medium
were collected, stored at −80 °C and replaced with fresh PBS. Total protein release was
quantified by means of the BCA assay (Thermo Scientific Pierce; Rockford, IL, USA),
using a BSA calibration line (0 to 2 mg/mL). PDBG-BB and VEGF were quantified using
ELISA kits (RayBiotech; Norcross, GA, USA), according to the manufacturer’s instructions.
Released TGF-β1 was quantified also with an ELISA kit after activation of the samples (100
μL) in 1N HCl (20 μL) for 10 min, followed by neutralization with 1.2 N NaOH/0.5 M
HEPES (pH 7.2–7.6; 20 μL). In brief, samples of release medium were incubated in 96-well
plates coated with monoclonal antibody to each growth factor for 2.5 h. The wells were
washed, and biotinylated antibody was added and incubated for 1 h. After washing, HRPconjugated streptavidin was added and wells were incubated for 45 min. Wells were washed,
3,3′,5,5′-tetramethylbenzidine substrate solution was added, and the wells were again
incubated for 30 min, so color could develop in proportion to the amount of the
corresponding growth factor. Finally, a stop solution was added to change the color from
blue to yellow and absorbance was measured at 450 nm. A standard curve was used to
determine the growth factor concentration.
2.3.5 Hemocompatibility—An activating complement test was carried out according to
the UNE-ISO 10993-4 standard protocol. PCL scaffolds (1.33 cm2) were incubated with
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human plasma. After 15 minutes, complement activity was measured with the Complement
Convertase assay (Haemoscan, Netherland).
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2.3.6 Cytocompatibility—Cytocompatibility tests of PCL and PRP-PCL scaffolds were
carried out in triplicate using murine fibroblasts (CCL-163, ATCC, USA) and human
adipose-derived mesenchymal stem cells (MSC, Invitrogen, USA). Scaffold disks (1.33
cm2) were sterilized in ethanol and placed in 24-well plates (LabClinics, Spain). Cells (2·104
cells/well) were seeded in each well and cultured for 7 days in a humidified atmosphere with
5% CO2 at 37 °C, renewing culture medium every second day. Fibroblasts were cultured in
1 mL DMEM medium (Dulbecco’s modified Eagle’s Medium F12-HAM, 10% fetal bovine
serum, 13 μg/mL gentamicin), while MSC were cultured in 1 mL complete MesenPro
medium (MesenPro RS, 10% growth supplement MesenPro RS, Gibco, USA) with
antibiotics (penicillin 100 IU/mL and streptomycin 100 μg/mL). After incubation, cells were
stained with calcein (1 mg/mL):propidium iodide (1 mg/mL):PBS (pH 7.4) 1:1:98 solution
and again incubated in darkness for 10 minutes. Cell viability was evaluated from images
obtained using a Laser Confocal Fluorescence Microscope (LCS, Leica Microsystems,
Germany).
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2.3.7 Cell attachment and proliferation—MSC proliferation on PCL and PRP-PCL
scaffolds was evaluated using a MTT proliferation kit (Roche, Switzerland). Briefly, MSC
(2·104 cells/well) were cultured on the scaffolds in 24-well plates for up to 7 days in a
humidified atmosphere with 5% CO2 at 37°C. At the end of the culturing period, each
sample was incubated for 4 hours with the MTT reagent at 37°C, and overnight with the
detergent included in the kit. Final solutions were read at 550 nm (UV Bio-Rad Model 680
microplate reader, USA). The experiments were carried out in triplicate.
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In parallel, cell attachment to the scaffolds was evaluated at 36 hours and 6 days. The
culture medium was removed and the cells were fixed with paraformaldehyde (4%) for 10
minutes and washed with PBS 3 times. Then, 0.2 % (w/v) Triton in phosphate buffer pH 7.4
was added to the immobilized cells, which were then incubated for 5 minutes and washed
three-times with PBS. The cell nuclei were stained with Hoescht dye solution (Sigma
Aldrich, USA). After incubation for 30 minutes at dark, the fiber mats were washed again
with phosphate buffer pH 7.4, mounted on glass slides using an anti-fading solution (BioRad Laboratories, USA), and stored at −20°C for 24 h. The cells were visualized using a
Confocal Spectral Microscope Leica TCS-SP2 (LEICA Microsystems Heidelberg GmbH,
Mannheim, Germany). Counting of stained cell nuclei was performed, for two different
pieces of scaffold, in 5 different fields of 0.25 mm2.
Gene expression analysis of MSC was performed after cultured on PRP-PCL scaffolds using
reverse transcriptase polymerase chain reaction (RT-PCR) and compared to that recorded for
PCL scaffolds (non PRP-treated cells). The gene expression of collagen I and III and also
lipoprotein lipase (LPL), osteocalcin (BGLAP), tenomodulin (TNMD) and aggrecan
(ACAN) was recorded (n=3, for each group). Total RNA was extracted from 3, 7 and 14day samples, purified using the Qiagen RNeasy Kit® and assessed for its purity and
concentration of RNA by spectrophotometry. Quantitative real-time polymerase chain
reaction was performed in triplicate as indicated by the manufacturer. TaqMan® gene
Mater Sci Eng C Mater Biol Appl. Author manuscript; available in PMC 2015 July 01.
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expression assay was used to analyze LPL, BGLAP, COL1A1, COL3A1, TNMD and
ACAN expression (Hs 00173425_m1, Hs 01587814_g1, Hs 00164004_m1, Hs
00943809_m1, Hs00223332_m1, Hs 00153936_m1 respectively; Applied Biosystems, UK)
and normalized against GAPDH (Hs 02758991_g1; Applied Biosystems, UK). Data were
analyzed for relative expression using comparative cycle threshold (Ct) method. Results
were referred to day 0 gene expression.
2.3.8 Angiogenic activity on chicken chorioallantoic membrane (CAM)—
Fertilized hen eggs were washed with 70% ethanol and incubated at 37°C and 60% RH. On
day 3 albumen (2 mL) was aspirated from the acute pole of the egg to create a false air sac
directly over the CAM, and a square window was cut with forceps. The window was closed
with transparent tape and eggs were returned to incubation until day 8, when the sterilized
PCL and PRP-PCL scaffolds were implanted. Then, incubation was continued until day 12
[25]. Finally, CAM was fixed with formaline 10% for 60 minutes, cut with a scalpel,
transferred to a culture plate, cleaned with PBS and observed at 5×.
2.4 Statistical analysis
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All results are reported as mean with associated standard deviation. Statistical analysis was
performed using SPSS version 20, and a p value ≤ 0.05 was considered statistically
significant. Furthermore, one-way ANOVA analysis with Tukey’s LSD post-hoc test was
used to evaluate differences between groups.

3. Results and Discussion
3.1 Preparation and characterization of PRP
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PRP is attracting considerable attention for the bioactivation of scaffolds due to the
simplicity, safety and cost-effectiveness of autologous blood preparation [26]. Freeze-thawfreeze (FTF) cycles constitute an easy and inexpensive way to activate PRP retaining all
proliferative and adhesive properties [22]. FTF enhances platelet lysis and cytokines
expression avoiding the use of CaCl2 or thrombin, which in turn interfere with cell
proliferation and differentiation. Moreover, it has been previously proved that growth factors
from frozen platelets remain viable after lyophilization [27]. In the freeze-dried activate
PRP, contents in total protein and in VEGF were quantified as 79.5% (s.d. 1.4%) and 4.40
(s.d. 0.45) pg/mg, respectively.
Before PRP incorporation onto the PCL scaffold, several tests were carried out to confirm
the ability of PRP to stimulate the proliferation of MSC. Cell growth was monitored for 11
days (Figure 1). Compared to the growth recorded in culture medium without PRP, addition
of PRP (up to 10 vol.%; equivalent to 7.25 mg freeze-dried PRP/mL) remarkably enhanced
the proliferation of MSC after 3 and 7 days, but differences decreased at day 11 because
cells became confluent on the well surface. This finding is in agreement with previous
reports on the positive effect of PRP at low concentration in culture medium, while high
concentrations of PRP suppressed viability and proliferation [28]. Moreover, MSC cultured
in the presence of 10 vol.% PRP produced more extracellular matrix (Alcian Blue staining
of sulfated glycosaminoglycans, GAG). In contrast, typical staining of ALP (red points), an
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early marker of osteoblast differentiation, was negative in both control and PRP-treated
MSC, which indicates that the cells did not differentiate to osteoblast linage (Figure S1 in
Supplementary Material). Although the literature about the effect of PRP on ALP activity is
somehow contradictory, activation of ALP seems to depend on the presence of calcium
during PRP activation or on the use of calcium-bearing scaffolds [29, 30]. The FTF method
used in the present study to activate PRP prevented osteogenic differentiation of MSC.
Moreover, the positive effect of PRP on MSC proliferation led to a higher extracellular
matrix production as shown in the GAG concentration.
3.2 PCL electrospun fibers
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PCL has suitable properties for electrospinning [14, 31]. 70–90 KDa PCL solution at 10 wt.
% provided adequate viscosity for processing, resulting in fibers with intermediate
degradation time. Solvents used in this study were DMF (high boiling point and polarity)
and THF (low boiling point and polarity); both are Class 2 solvents (mid toxicity) in the
European Pharmacopoeia, and THF is even considered Class 3 (low toxic potential) in The
United States Pharmacopeia and The National Formulary (USP–NF). The mixture of both
solvents was shown adequate to form homogeneous PCL solutions that were
electrospinnable and afforded defect free nanofibers.
The fiber mats (0.8 mm thickness) were formed by nonwoven, porous interconnected
structures with randomly dispersed nanofibers of diameter around 0.30–0.35 μm (Figure 2;
greater magnifications in Figure S2 in Supplementary Material). Pore size ranged between 5
and 10 μm. This diameter could be easily tuned if required for a particular application [5].
Hydrolytic degradation of PCL scaffolds in phosphate buffer pH 7.4 resulted in loss of
weight of ca. 10% after 50 days (Figure S3 in Supplementary Material), in agreement with
previous reports [32]. Despite of having larger surface area, fiber mats of synthetic
biodegradable polyesters degrade at slower rate than cast films because the acidic byproducts of degradation at the ester bond, which autocatalyze the degradation reaction, can
diffuse out of the scaffold structure more rapidly than from physically denser polymer films
[33, 34]. Accelerated hydrolytic experiments carried out by immersion of the PCL fiber mats
in NaOH 4M resulted in the disintegration of all specimens within a few minutes.
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Preliminary screening of hemo- and cyto-compatibility of PCL scaffolds was carried out to
ensure that no residual solvents or impurities might compromise their performance. PCL
scaffold behaved as complement non-activating biomaterial (0.05 OD/24h/cm2) [35] and
showed an excellent compatibility with two cell lineages, murine fibroblasts and human
MSC. Calcein-propidium iodide (live-dead) staining at day 7 showed a majority of viable
cells with barely red (dead) staining, indicating good viability of both fibroblasts and MSC
(Figure 3). In the case of fibroblasts, the roughness of the scaffold did not allow to capture
all confocal planes, resulting in loss of information in the micrographs. Both cells types
successfully attached and proliferated on PCL scaffolds after one week, confirming the
suitability of the electrospun nanofibers as cell supports.
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3.3 PRP-PCL scaffold
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Once confirmed the bioactivity of PRP and the cytocompatibility of the PCL fibers, PRPadsorbed PCL scaffolds were prepared. PCL scaffolds were sterilized prior PRP adsorption
in order to avoid loss and inactivation of growth factors. Coating with PRP was carried out
by impregnation followed by freeze-drying, as this latter technique has been previously
shown not to alter the growth factors properties on proliferation and tissue regeneration [24,
27]. The density of the coating may depend on the concentration of growth factors and on
the time that the scaffold remains immersed in PRP solution before freeze-drying. In our
case, immersion of PCL in PRP solution (72.5 mg solids/mL) was carried for 4 hours at 4°C
and resulted in 2.85 (s.d. 0.14) mg PRP per mg scaffold. The difference in weight among
replicates was below 5%, which indicates quite uniform coating. FTIR analysis, SEM
microphotographs and water contact angle values confirmed PRP adsorption on the scaffold
structure.

NIH-PA Author Manuscript

No differences in the FTIR spectra of PCL were observed before and after electrospinning
(Figure 4), which showed the characteristic assignments: CH2 asymmetric and symmetric
stretching at 2900–3000 and 2800–2900 cm−1, respectively; C=O stretching at 1700–1760
cm−1; CH scissoring and symmetric deformation at 1350–1480 cm−1; O–C–O stretching at
1150–1200 cm−1; C–O stretching at 1100–1150 cm−1; C–C stretching at 1000–1100 cm−1;
C–O–C symmetric stretching at 900–1000 cm−1 and CH2 rocking at 500–900 cm−1 [36].
The spectrum of freeze-dried PRP presented amide I and II peaks at 1660 and 1550 cm−1,
respectively, and a broad band in the 3300–3500 cm−1 region assigned to NH groups from
proteins (3400–3500) and water (3300–3500) vibrations. Furthermore, PCL fibers coated
with PRP exhibited a combination of bands found in both materials, being most significant
the presence of the C=O stretching at 1700–1760 cm−1 from PCL, and the amide I and II at
1660 and 1550 cm−1 from proteins present in PRP. The peak at 2400 cm−1 in the spectrum
of freeze-dried PRP can be attributed to CO2 background, as the highly porous structure of
the powder prevents tight compaction on the ATR crystal. PCL fibers coated with PRP did
not present the CO2 peak, indicating its removal from the scaffold.
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In a preliminary test we observed that the freeze-drying process did not alter the nanofibrous
structure of PCL scaffolds. Once processed with PRP, the appearance of the mat became
different as PRP was homogeneously adsorbed on the scaffold in a sponge-like arrangement.
Nevertheless, the average diameter of visible nanofibers was similar to that of pristine PCL
fibers (Figure 2). Once immersed in culture medium, a PRP gel-like film was formed on the
scaffold, supported by the solid nanofibers that provide the nanoscale architecture for cell
attachment. Differently from the hydrophobic surface of PCL scaffold, which exhibited a
mean water contact angle of 122° that remained constant for more than 5 minutes (Figure S4
in Supplementary Material), PRP coating led to highly hydrophilic surfaces. In fact, PRPPCL scaffold absorbed the water drop in a few seconds, indicating that PRP has a
hydrophilizing effect on the nanofibers. It has been previously demonstrated for collagenimmobilized PCL scaffolds that hydrophilization notably improves the attachment,
spreading and proliferation of fibroblast cells compared to the pristine material [37]. Thus,
the PRP-PCL scaffold containing growth factors and proteins could act as substrate for cell
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attachment and create a microenvironment rich in growth factors that improves cell
proliferation.
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Since mechanical features are quite relevant for the success of the scaffold, the effects of the
freeze-drying process and the coating with PRP were analyzed in detail. Freeze-drying of
PCL solely scaffolds (without PRP) did not alter the Young’s modulus, tensile stress and
tensile strain (Figure 5). The Young’s modulus values obtained for PCL fibers were in
between those reported for PCL extruded films (190±6 MPa) and for other PCL porous
electrospun mats (3.8±0.8 MPa) [38]. Further, the PRP coating did not significantly modify
the Young’s modulus compared to pristine nanofibers (54.50±15.09 vs. 42.32±15.09 MPa)
and led to a minor decrease in tensile stress (7.46±0.84 vs. 10.78±3.01 MPa) and tensile
strain (2.01±0.20 vs. 2.56±0.21 mm). These results suggest that the material becomes stiffer
after PRP addition and can be torn apart more easily, although the small magnitude of these
changes should not have negative repercussions on the potential clinical application of PCL
electrospun fibers.
3.4 Growth factors release from PRP-PCL scaffolds
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Since PRP has a complex composition, release experiments were carried out by monitoring
the release of the total amount of protein and three representative growth factors from pieces
(1.33 cm2) of UV-sterilized PRP-PCL scaffolds immersed in PBS (Figure 6). A relevant
amount of protein (9.63 mg) was released in the first 4 hours in PBS; at day 7, the amount of
protein accumulated in the release medium was 11.18 mg (nearly 100% released). VEGF
also showed a burst in the first hours of the test; the maximum amount released being 59.13
pg at day 7 (which corresponded to 94.3% initial loading). By contrast, TGF-β1 and PDGFBB (the most potent isoform of PDGF) showed sustained release patterns. The amount of
TGF-β1 in the medium progressively increased reaching a maximum at day 3, with ~684 pg
released. PDGF-BB was released in a more sustained manner during the 7 days of the study;
the amount released up to day 7 (1186 pg) was 2.6 times greater than that released during
the first 4 h in PBS. This release behavior is in agreement with a recent report by Anitua and
coworkers [39] on grade IV titanium discs coated with activated PRP, who found that PDGF
was released in a more sustained way than VEGF or TGF-β1. Nevertheless, in our work the
release was slightly slower, which is probably because PRP was more tightly embedded
onto the PCL nanofibers, compared to the titanium surfaces. The greater retention can be
favored by the fact that PRP was immobilized onto the PCL scaffold by means of freezedrying, which may favor interactions with the substrate [40]. In this context, interactions
between PDGF and alginate have been found responsible for the slower release of this
growth factor, compared to the others, from alginate capsules [41]. It is interesting to note
that the total amount released of each growth factor from the PRP-PCL scaffolds are slightly
greater than those reported previously, which can be related to the fact that the PRP
activation by means of freeze-thaw cycles as used in our study is more efficient in making
the growth factors available from the platelets than activation using thrombin with CaCl2
[22]. Moreover, the small dispersion of the values of the amount of growth factors released
from several separately prepared PRP-coated scaffolds (Figure 6) is an index of the
robustness of the preparation method.
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3.5 MSC proliferation on PRP-PCL scaffolds
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The effect of PRP on the attachment and proliferation of MSC on the scaffolds is
summarized in Figure 7. MSC proliferation was found to be higher on PRP-PCL scaffold
than on PCL scaffold; the differences becoming greater as the time progressed. PRP coating
facilitated the wetting of the scaffold and made growth factors and cell recognition sites
available to the cells, endowing the scaffold with high cell-loading properties. The
progressive cell proliferation can be explained by the combined effect of the three growth
factors monitored (see Figure 6). VEGF is known to stimulate MSC proliferation by
activation and downstream signaling of PDGF receptors. Both PDGF-BB which is a potent
mitogen, and TGF-β1 which increases MSC proliferation without bias towards the
chondrogenic lineage [42], were sustainedly released from the scaffold, which led to higher
proliferation levels as time progressed.
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Cell viability on the PRP-PCL scaffold was evidenced by means of calcein-propidium
iodide (live-dead) staining images of the MSC (Figure 8). After 7 days of incubation, PRPPCL scaffolds were completely covered by cells, while pristine PCL fibers presented lower
cell density. Although PCL fibers showed some autofluorescence, Hoechst staining enabled
the quantification of MSC cells attached to the PRP-PCL and the PCL scaffolds after 36 h
and 6 days (Figure S5 in Supplementary Material). MSC nuclei were stained in blue.
According to the number of nuclei stained in blue, the number of MSC on PRP-PCL
scaffolds was remarkably higher than on PCL scaffolds (Figure 9). After 36 h and 6 days,
cell counting in the PRP-PCL scaffold was almost 2-fold and 5-fold greater than the cell
count achieved with PCL scaffold. Thus, once again, the proliferating effect of PRP on MSC
was evidenced.
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RT-PCR analysis was performed to obtain additional data about the gene expression of
various cell lineages and collagens markers (Figure 10). There was no expression of
differentiation-related genes, which indicates that PRP did not induce MSC differentiation.
After 3 days, the presence of PRP in the PCL scaffold decreased the expression of Col1a1,
but this expression was induced at day 7 and then decreased at day 10. Col3a1 analysis did
not result in any variation of gene expression between PCL scaffolds, regardless of the
presence or absence of PRP. Expressions of differentiation factors were negative in all
conditions, which suggests that there are no differentiation mechanisms in cells cultured
with PRP and PCL-scaffold.
3.6 Angiogenic activity
CAM test has been proposed as an alternative method to animal experimentation to evaluate
the biocompatibility of a material and, in particular, angiogenesis response [43, 44]. The
growth of blood vessels in the chicken CAM during embryo development was analyzed after
the contact of the CAM with PCL and PRP-PCL scaffolds for 5 days (Figure 11). Scaffold
with PRP induced a notable angiogenic effect on the allantoic vessels density with a clear
increase in the number of capillary blood vessels converging radially around the scaffold.
PRP-PCL scaffolds were entrapped into the CAM, differently to the PCL scaffolds, which
remained on the surface without appreciable interaction with CAM. Therefore, the gel rich
in growth factors (VEGF, TGF-β1 and PDGF, among others) formed around the PRP-PCL
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scaffold induced proliferation of epithelial and endothelial tissues, resulting in
neovascularisation and CAM growth around the scaffold [24, 45].
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Conclusion
The present study reports the development of an easy and effective procedure to treat PCL
electrospun scaffolds with PRP for potential tissue engineering applications. Impregnation
of PCL nanofibers by soaking in activated PRP followed by freeze-drying led to a solid
support suitable for the handling of PRP without loss of activity. Coating with PRP notably
improved hydrophilicity, mesenchymal stem cells attachment and proliferation on PCL
scaffold, without inducing differentiation to a particular linage. Moreover PRP-PCL
scaffolds were shown able to sustain the release of some growth factors, which may be
useful for a sequential delivery of essential components for tissue regeneration. The results
of this study prove the interest of PRP-PCL scaffolds as tissue engineering platforms by
promoting cell attachment, proliferation and CAM angiogenesis. In vivo studies are needed
to determine the recruitment effect of PRP-PCL scaffolds over the native cells.
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Highlights
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•

Platelet-rich plasma (PRP) can be adsorbed on electrospun fibers via
lyophilization

•

PRP coating enhanced mesenchymal stem cells adhesion and proliferation on
scaffolds

•

PRP-coated scaffolds showed sustained release of growth factors

•

Adsorbed PRP provided angiogenic features

•

PRP-poly(ε-caprolactone) scaffolds hold promise for tissue regeneration
applications
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Figure 1.

Effect of addition of PRP into culture medium on the proliferation of human MSC. Cells
(2·104) were seeded in 1 mL of MSC medium (control; white columns) or in 1 mL of PRPrich medium (grey columns) and proliferation (MTT) was measured at 3, 7 and 11 days.
Error bars represent standard deviations of three independent experiments.
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Figure 2.

SEM microphotographs of pristine PCL (A) and PRP-PCL (B) scaffolds at 1000×. Scale bar
is 50 μm.
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Figure 3.

Calcein (left)-propidium iodide (right) staining of fibroblasts (A) and MSC (B) grown on
PCL scaffolds after 7 days. The green stains on left column show live cells and red stains on
the right column show dead cells.
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Figure 4.

FTIR spectra of lyophilized PRP, PCL pellet, and PCL and PRP-PCL scaffolds. PRP-PCL
scaffolds exhibited a combination of bands found in both PRP (mainly amide I and II at
1660 and 1550 cm−1) and PCL (C=O stretching at 1700–1760 cm−1). The peak at 2400
cm−1 in the spectrum of lyophilized PRP was due to CO2 background.
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Figure 5.

Young’s modulus, tensile stress and tensile strain of pristine PCL scaffolds (white columns),
freeze-dried PCL solely scaffolds (striped columns), and PRP-PCL scaffolds (grey
columns). Statistically significant differences (p > 0.05) of the PCL nanofibers upon
adsorption of PRP compared to pristine PCL nanofibers are indicated with an asterisk.
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Figure 6.

Cumulative release profiles of total protein and of growth factors PDGF-BB, TGF-β1, and
VEGF from UV-sterilized PRP-PCL scaffolds (1.33 cm2) in PBS at 37°C.

Mater Sci Eng C Mater Biol Appl. Author manuscript; available in PMC 2015 July 01.

Díaz-Gómez et al.

Page 22

NIH-PA Author Manuscript
NIH-PA Author Manuscript

Figure 7.

MSC proliferation on the PCL (white columns) and PRP-PCL (grey columns) scaffolds at 1,
3 and 7 days.
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Figure 8.

Live-dead staining images of MSC grown on PCL (A) and PRP-PCL (B) scaffolds after 6
days incubation. Live cells are shown in green and dead cells in red.
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Figure 9.
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Number of cells attached to PCL (white column) and PRP-PCL (grey column) scaffolds
expressed as percentage of the seeding density after 1.5 and 6 days.
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Figure 10.

Reverse transcriptase polymerase chain reaction (RT-PCR) measured expression of Col1a1
and Col3a1 in MSC grown on PCL (white columns) and PRP-PCL (grey columns) scaffolds
at 3, 7 and 10 days.
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Figure 11.

Effect of PCL (A) and PRP-PCL (B) scaffolds on CAM angiogenesis at day 12 of
incubation of fertilized hen eggs.
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